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Airway epithelial cell necroptosis contributes to asthma
exacerbation in a mouse model of house dust mite-induced
allergic inflammation
Nikos Oikonomou 1, Martjin J. Schuijs2, Antonis Chatzigiagkos1, Ariadne Androulidaki1, Vassilis Aidinis3, Hamida Hammad2,4,
Bart N. Lambrecht2,4,5 and Manolis Pasparakis1
Regulation of epithelial cell death has emerged as a key mechanism controlling immune homeostasis in barrier surfaces.
Necroptosis is a type of regulated necrotic cell death induced by receptor interacting protein kinase 3 (RIPK3) that has been shown
to cause inflammatory pathologies in different tissues. The role of regulated cell death and particularly necroptosis in lung
homeostasis and disease remains poorly understood. Here we show that mice with Airway Epithelial Cell (AEC)-specific deficiency of
Fas-associated with death domain (FADD), an adapter essential for caspase-8 activation, developed exacerbated allergic airway
inflammation in a mouse model of asthma induced by sensitization and challenge with house dust mite (HDM) extracts. Genetic
inhibition of RIPK1 kinase activity by crossing to mice expressing kinase inactive RIPK1 as well as RIPK3 or MLKL deficiency
prevented the development of exaggerated HDM-induced asthma pathology in FADDAEC-KO mice, suggesting that necroptosis of
FADD-deficient AECs augmented the allergic immune response. These results reveal a role of AEC necroptosis in amplifying airway
allergic inflammation and suggest that necroptosis could contribute to asthma exacerbations caused by respiratory virus infections
inducing AEC death.
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INTRODUCTION
Asthma is a chronic inflammatory disorder of the airways that is
characterized by eosinophilia and lymphocytosis, goblet cell
metaplasia, smooth muscle activation and airway hyperreactivity.
In most cases of asthma this chronic airway inflammatory
response is orchestrated by the secretion of type 2 cytokines like
IL-4, IL-5 and IL-13 from activated TH2 cells.
1,2 Accumulating
evidence suggests that epithelial cells of the lung play important
roles in inducing type 2 immune responses against inhaled
allergens such as House Dust Mites (HDM). Acting as barrier,
sentinel cells, airway epithelial cells (AECs) recognize allergens
with Pattern Recognition Receptors like TLR4 and C-type lectin
receptors or protease-activated receptors and respond by releas-
ing cytokines like TSLP, IL-33, IL-1α, GMCSF and chemokines such
as CCL2, CCL3 and CCL20, all of which induce a pro-allergic
phenotype on Dendritic Cells (DCs).3
Besides their contribution to the activation of type 2 innate and
adaptive immune responses, AECs are also the main targets of
numerous inhaled toxicants and inflammatory mediators that are
released by activated T cells, eosinophils or other immune cells
that can cause cell death. Shedding of AECs is a typical feature in
biopsies from asthma patients4–6 and ultrastructural studies have
indicated increased frequency of cell death in AECs especially in
cases of severe asthma.7 The increased occurrence of apoptotic
cells in pediatric asthma8 and the presence of desquamated
epithelial cells known as Creola bodies in the sputum of infants
with viral bronchiolitis, which has been correlated with the
subsequent development of wheezing and asthma,9,10 indicate a
link between epithelial cell death and the pathogenicity of
asthma. Moreover, persistence of dying AECs due to insufficient
clearance exacerbated allergic airway inflammation.11
In addition to the structural consequences of epithelial damage,
death of AECs might also affect immunological parameters of
allergic airway inflammation. A recent study suggested that HDM
causes DNA double strand breaks in AECs that correlated with
increased presence of cleaved caspase 3+ cells and elevated
cytokine production.12 The propensity of HDM to induce type 2
immune responses correlates with its ability to cause the release
of uric acid,13 ATP,14 IL-1α15 and IL-33 from AECs. Notably, these
endogenous factors known as alarmins or Danger Associated
Molecular Patterns are potent inducers of immune responses that
are released from cells undergoing immunogenic types of cell
death.16–18 Recent research has highlighted the importance of
regulated cell death in tissue homeostasis and inflammation.19,20
Necroptosis has been recently identified as a new type of
regulated necrotic cell death that stimulates potent inflammatory
responses.19,21 Receptor interacting protein kinase 3 (RIPK3)
induces necroptosis by phosphorylating the pseudokinase Mixed
lineage kinase like (MLKL), which executes cell death by damaging
the plasma membrane.19,21 RIPK1 is a key mediator of necroptosis
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downstream of death receptors or Toll-like receptors (TLR3 and
TLR4). RIPK1 exhibits kinase-independent scaffolding functions
that inhibit cell death and favor cell survival and NF-κB-dependent
inflammatory gene expression.22,23 On the other hand, activation
of the kinase activity of RIPK1 facilitates the formation of death-
inducing protein complexes that trigger cell death by activating
apoptosis or necroptosis. Genetic or pharmacological inhibition of
caspase-8 or the Fas-Associated with Death Domain (FADD)
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adapter protein favors the formation of the necrosome, a protein
complex facilitating the activation of RIPK3 and subsequent
phosphorylation of MLKL for the induction of necroptosis.19
Genetic mouse model studies showed that FADD or caspase-8
deficiency caused RIPK3-MLKL-dependent necroptosis in epithelial
cells causing inflammation in barrier tissues such as the skin and
the intestine, identifying epithelial cell necroptosis as a potent
driver of inflammation.24–27 Although apoptosis is generally
considered non-immunogenic, accumulating evidence suggests
that FADD-caspase-8-dependent cell death can also cause
inflammation.19
The role of RIPK3-MLKL-induced necroptosis and FADD-caspase-8-
dependent apoptosis in lung homeostasis, inflammation and
disease remains poorly explored. Here we investigated the potential
involvement of AEC necroptosis and apoptosis in the development
of HDM-induced asthma-like pathology. Our results showed that
mice with AEC-specific deficiency in FADD (FADDAEC-KO) developed
exaggerated allergic airway inflammation in response to HDM
sensitization and challenge compared to their Faddfl/fl littermates.
Inhibition of RIPK1 kinase activity as well as RIPK3 deficiency both
prevented the excessive activation of HDM-induced allergic
inflammation in the lungs of FADDAEC-KO mice, suggesting that
AEC necroptosis greatly contributes to the amplification of the
immune response.
RESULTS
AEC-specific ablation of FADD exaggerates HDM-induced airway
inflammation
In order to study the role of epithelial cell death in the
development of HDM-induced immunopathology, we generated
mice with AEC-specific deletion of FADD (FADDAEC-KO) by crossing
mice carrying Fadd floxed alleles (Faddfl/fl)28 with Scgb1a1-Cre
transgenic mice expressing Cre under the control of the rat
Scgb1a1 promoter.29 Immunohistochemical analysis of lung
sections from FADDAEC-KO mice with anti-FADD antibodies
revealed efficient ablation of FADD in bronchial and bronchiolar
epithelial cells, while neighboring alveolar epithelial and immune
cells expressed the protein (Fig. 1A). Furthermore, immunoblot
analysis of primary AEC lysates showed strong reduction of FADD
expression in FADDAEC-KO mice (Fig. 1B). FADDAEC-KO mice were
born at a Mendelian ratio and did not develop any apparent
abnormalities, showing that FADD ablation in AECs did not disrupt
normal lung homeostasis.
To study how AEC-specific FADD ablation affected the
pathogenesis of allergic airway inflammation we analyzed the
response of FADDAEC-KO mice and their Faddfl/fl littermates to a
well-established model of asthma induced by instillation of
HDM.15 To this end, mice were sensitized with intranasal
instillation of 1 μg HDM on day 0 followed by challenge with 10
μg HDM on 5 consecutive days starting 1 week after sensitization.
Mice were analyzed 3 days after the last HDM instillation. Faddfl/fl
mice, as expected, developed all the cardinal features of asthma
including increased infiltration of immune cells, TH2 cytokine
production by Mediastinal Lymph Nodes (MLN) cells and
increased titers of IgE antibodies in the serum (Fig. 1D, E, F). In
contrast, FADDAEC-KO mice exhibited an exacerbated inflammatory
phenotype characterized by severe eosinophilia, lymphocytosis
and increased infiltration of CD11c+MHCIIhigh DCs and CD11b+GR-
1+ neutrophils (Fig. 1C, D). Toluidine blue staining of lung sections
revealed no difference in the recruitment of mast cells in the lungs
of FADDAEC-KO compared to Faddfl/fl mice (data not shown).
Moreover, in ~40% of FADDAEC-KO mice infiltration of inflammatory
cells was not limited around airways and blood vessels but instead
expanded into the parenchyma, which in the most severe cases
obliterated the alveolar compartment of at least one lung lobe
(Fig. 1C, HDM). The cellular infiltrate consisted mainly by
eosinophils and contained macrophages that appeared multi-
nucleated bearing the morphological characteristics of giant cells.
Further histopathological examination of lung sections revealed
the presence of dense cellular aggregates around airways
reminiscent of inducible bronchus-associated lymphoid tissue
(iBALT). These structures were much more common in the lungs of
FADDAEC-KO mice, especially in those that were more severely
affected. Quantitative PCR analysis of the expression levels of
Cxcl13, a chemokine known to induce iBALT through the
recruitment of cells like B cells and Tfh cells, showed that
FADDAEC-KO mice produced higher levels of the chemokine when
compared to Faddfl/fl mice (Fig. S1A), suggesting that FADD
deficiency in AECs can potentiate iBALT formation upon allergen
sensitization and challenge. MLN cells from FADDAEC-KO mice
produced mildly elevated amounts of IL-13 but similar amounts of
IL-5 compared to cells from Faddfl/fl littermates when re-stimulated
ex vivo with HDM (Fig. 1E). However, MLN cells from FADDAEC-KO
mice secreted increased amounts of IL-17A compared to cells
from Faddfl/fl mice, indicating that epithelial cell FADD deficiency
results in an amplification of TH17 responses (Fig. 1E). Serum IgE
levels were equal between the two genotypes (Fig. 1F). Quanti-
tative RT-PCR analysis of mRNA isolated from lung tissue showed
mildly increased expression of Il-4, Il-13, Tnf, Cxcl1, Ccl11 and Il-17,
as well as statistically significant increase of Ccl2 and Ccl3
expression in FADDAEC-KO compared to Faddfl/fl mice (Fig. 1G).
Sensitization to HDM depends on the activation of DCs and their
migration from the lungs to the draining lymph nodes, where they
activate naïve CD4+ T cells into TH2 effector cells.
30 Analysis of DC
subsets in MLNs 3 days after a single HDM instillation using flow
cytometry revealed that the numbers of the different DC subsets
were evidently increased in the lymph nodes of FADDAEC-KO when
compared to Faddfl/fl mice, with a predominance of CD103+ DCs
(Fig. 1H). Collectively, these results showed that FADD ablation in
AECs exacerbated HDM-induced inflammation, an effect that
appears to be the result of the coordinated actions of both
adaptive and local innate immune activation.
RIPK1 kinase activity drives exacerbated HDM-induced airway
inflammation in FADDAEC-KO mice
Recent studies highlighted the importance of RIPK1 as a regulator
of cell death and inflammation.31,32 Whereas RIPK1 kinase activity
induces apoptosis and necroptosis, RIPK1 exhibits also kinase-
independent scaffolding functions that inhibit apoptosis and
Fig. 1 Airway epithelial FADD deficiency results in exacerbated HDM-induced allergic inflammation. A Representative images of lung
sections from the indicated genotypes immunostained for FADD. Bronchioles (left panel) and bronchi (right panel) are depicted. Arrows
indicate AECs and arrowheads indicate parenchymal or immune cells (n= 5 per genotype) Scale bar, 50 μΜ. B Immunoblot analysis for FADD
and Cre expression in lysates of AECs or lung tissue isolated from the indicated genotypes. Tubulin is used as a loading control. C
Representative images of H&E stained lung sections from Faddfl/fl and FADDAEC-KO mice sensitized and challenged with PBS or HDM and
clinical scores of peribronchial and parenchymal inflammation. Scale bars, 100 and 200 μM. D Differential cell count analysis with flow
cytometry in BALF cells from the indicated genotypes. E Levels of cytokines in the supernatants of MLN cells after ex vivo stimulation with
HDM. F Serum levels of total IgE. G qRT-PCR analysis of the indicated cytokines in whole lung mRNA isolated from Faddfl/fl and FADDAEC-KO
mice. H FACS analysis of DC subsets recruited in MLNs 3 days after HDM exposure. For C–G data are pooled from two experiments, n= 9–11
for HDM, n= 4–6 for PBS. For H data from two experiments for CD11b and CD103 with n= 3–9 and one experiment for MoDCs with n= 3–5.
Error bars indicate SEM. P values reflect the Mann–Whitney U test: *P < 0.05, **P < 0.01, ***P < 0.001.
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necroptosis.19,33,34 In order to investigate the role of RIPK1 in AECs
we generated RIPK1AEC-KO mice by crossing the Scgb1a1-Cre mice
to mice bearing loxP-flanked Ripk1 alleles.31 In contrast to Ripk1−/−
mice, which die perinatally exhibiting a multi-organ inflammatory
response that is caused by FADD-caspase-8-mediated apoptosis
and RIPK3-MLKL-dependent necroptosis,22,23,35 RIPK1AEC-KO mice
were born at Mendelian ratio and were healthy and fertile with no
apparent pulmonary pathology (data not shown). To assess
whether epithelial RIPK1 deficiency affects the pathogenesis of
asthma we analyzed the response of RIPK1AEC-KO and Ripk1fl/fl
littermates to HDM-induced airway inflammation. HDM sensitiza-
tion and challenge of RIPK1AEC-KO mice induced features of asthma
pathology that were indistinguishable from the disease developing
in their Ripk1fl/fl littermates (Fig. S2A–D), showing that AEC-specific
deletion of RIPK1 did not considerably affect HDM-induced allergic
airway inflammation.
We reasoned that AEC-specific FADD deficiency might cause
exacerbated airway inflammation in response to HDM by
sensitizing AECs to necroptosis, as was previously shown in mice
lacking FADD specifically in epidermal keratinocytes or intestinal
epithelial cells.24,25 RIPK1 kinase activity is required for TNFR1- and
TLR3/4-induced necroptosis in cells that lack FADD or caspase-8 or
are treated with caspase inhibitors.19 To address whether the
kinase activity of RIPK1 might be implicated in the development of
more severe HDM-induced airway inflammation in FADDAEC-KO
mice, we crossed them with Ripk1D138N/D138N mice expressing a
kinase inactive mutant form of RIPK1.36 Assessment of HDM-
induced airway inflammation revealed that Faddfl/fl Ripk1D138N/
D138N mice developed similar lung pathology compared to Faddfl/fl
animals (Fig. 2A–C), showing that lack of RIPK1 kinase activity did
not affect HDM-induced asthma pathology in mice with intact
FADD signaling. However, comparison of HDM-induced airway
inflammation between FADDAEC-KO and FADDAEC-KO Ripk1D138N/
D138N mice revealed that lack of RIPK1 kinase activity strongly
attenuated the exacerbated HDM-induced pathology observed in
FADDAEC-KO mice as judged by histopathological examination of
lung sections (Fig. 2A), assessment of immune cell infiltration
(Fig. 2B) and measurement of serum IgE levels (Fig. 2C). Moreover,
loss of RIPK1 kinase activity significantly suppressed IL-17A
production in ex vivo restimulated MLN cells from FADDAEC-
KORipk1D138N/D138N mice (Fig. 2D), suggesting a critical role of the
kinase activity of RIPK1 in mediating allergen-induced TH17
responses when FADD signaling is compromised in AECs. In
addition, qRT-PCR analysis of innate and adaptive immune
cytokines and chemokines revealed that FADDAEC-KORipk1D138N/
D138N mice expressed reduced levels of Il-5, Il-13 and Il-17A as well
as Ccl2, Ccl3 and Tnf in their lungs compared to FADDAEC-KO mice
(Fig. 2E). Collectively, these results showed that RIPK1 kinase
activity is required for the development of exacerbated HDM-
induced airway inflammation in FADDAEC-KO mice, suggesting that
RIPK1-mediated necroptosis of FADD-deficient AECs contributes
to the more severe pathology.
RIPK3-MLKL-dependent AEC necroptosis causes exacerbated
HDM-induced airway inflammation in FADDAEC-KO mice
To directly assess the potential contribution of RIPK3-mediated
necroptosis of FADD-deficient AECs in exacerbating HDM-induced
airway inflammation, we sensitized and challenged FADDAEC-KO
Ripk3−/− mice and the respective control mice (Faddfl/fl, FADDAEC-KO
and Faddfl/fl Ripk3−/−) with HDM. Comparison of Faddfl/fl Ripk3−/−
with Faddfl/fl mice revealed that RIPK3 deficiency caused a mildly
increased HDM-induced pathology, manifesting with slightly
elevated numbers of infiltrating eosinophils and T cells, as well as
mildly increased amounts of serum IgE and IL-13, IL-5 and IL-17
protein levels in the lung (Fig. 3A–D). Although this effect was not
very strong it was consistent suggesting that systemic RIPK3
deficiency results in a mild exacerbation of HDM-induced airway
inflammation. In contrast, RIPK3 deficiency strongly attenuated the
exacerbated airway inflammation of FADDAEC-KO mice, with
FADDAEC-KO Ripk3−/− mice exhibiting HDM-induced pathology
similar to Faddfl/fl Ripk3−/− mice. Inflammatory cell infiltration in
the lungs of FADDAEC-KO Ripk3−/− mice was limited in areas around
airways and the vasculature similarly to the Faddfl/fl Ripk3−/− control
mice (Fig. 3A). In line with the histological findings, RIPK3 deficiency
attenuated the inflammatory cell recruitment into the lungs since
the numbers of eosinophils, T cells, DCs and neutrophils in lungs
from double deficient FADDAEC-KO Ripk3−/− mice were normalized
to the level of the Faddfl/fl Ripk3−/− controls (Fig. 3B). Moreover,
FADDAEC-KO Ripk3−/− mice showed similarly elevated protein levels
of cytokines in the lung compared to Faddfl/fl Ripk3−/− mice
(Fig. 3E). Interestingly, RIPK3 deficiency greatly reduced the
expression of Cxcl13 in the lungs of FADDAEC-KO Ripk3−/− mice
(Fig. S1B), indicating that RIPK3-dependent necroptosis of FADD
deficient AECs induces Cxcl13 expression and iBALT formation. To
investigate whether RIPK3 deletion might have any effect on DC
mobilization during the sensitization phase, we assessed the
abundance of the various DC subsets in the MLNs 3 days after a
single HDM instillation. No significant differences were noted in the
numbers of CD11b+ and CD103+ DCs subsets that migrated to the
draining lymph nodes of Faddfl/fl or Faddfl/flRipk3−/− mice,
indicating that RIPK3 deficiency did not influence normal DC
activation (Fig. 3F). However, RIPK3 deficiency reduced the number
of migrated CD103+ DCs in the MLNs of FADDAEC-KORipk3−/− mice,
suggesting that RIPK3-dependent mobilization of this type of DCs
critically contributes to the exacerbated airway inflammatory
response to HDM in FADDAEC-KO mice. Taken together, these
results showed that RIPK3 deficiency strongly attenuated the
exacerbated HDM-induced airway inflammatory phenotype of
FADDAEC-KO mice, suggesting that RIPK3-mediated necroptosis is
responsible for the exaggerated inflammatory response consistent
with the findings on FADDAEC-KO Ripk1D138N/D138N mice. However,
RIPK3 deficiency also had an effect in mildly increasing HDM-
induced airway inflammation in mice with intact FADD signaling,
possibly via functions of RIPK3 in cell type(s) other than AECs.
RIPK3 mediates necroptosis by phosphorylating and activating
the downstream effector MLKL, however, RIPK3 has also been
implicated in necroptosis-independent signaling.37,38 To directly
assess the role of necroptosis in the exacerbated asthma-like
pathology of FADDAEC-KO mice we generated FADDAEC-KOMlkl−/−
mice (Fig. S3A) and subjected these mice and their littermate
controls to the same protocol of sensitization and challenge with
HDM. Similar to RIPK3 knockout, MLKL deficiency ameliorated the
enhanced inflammatory response in the lungs of FADDAEC-KO mice
as judged by histopathological examination (Fig. S3B) and by the
attenuated recruitment of immune cells into the lung (Fig. S3C).
These results provide additional genetic evidence that activation
of RIPK1-RIPK3-MLKL-dependent necroptosis in FADD deficient
AECs contributes to the severity of allergic airway inflammation.
The findings that RIPK1-RIPK3-MLKL signaling is required for the
exacerbated HDM-induced lung inflammation in FADDAEC-KO mice
suggested that FADD deficiency sensitized AECs to necroptosis
after exposure to HDM, which resulted in exaggerated inflamma-
tory responses. We therefore aimed to assess whether FADD-
deficiency indeed sensitized AECs to necroptosis. Phosphorylation
of MLKL by RIPK3 is an essential step for the induction of
necroptosis. We therefore attempted to assess the occurrence of
necroptosis in the lungs of mice at different time points after a
single intratracheal challenge with HDM by using antibodies
against phosphorylated RIPK3 or MLKL. However, unfortunately
we could not observe specific staining of RIPK3 or MLKL
phosphorylation in lung sections from HDM-treated Faddfl/fl or
FADDAEC-KO mice using available antibodies, therefore we could
not directly address the occurrence of necroptosis in these tissues
(data not shown). Nevertheless, western blot analysis of lung
homogenates showed that HDM instillation resulted in increased
expression of RIPK3 protein in the lungs of FADDAEC-KO mice
Airway epithelial cell necroptosis contributes to asthma exacerbation in. . .
N Oikonomou et al.
4
Mucosal Immunology _#####################_
Fig. 2 RIPK1 kinase activity drives exacerbated HDM-induced airway inflammation in FADDAEC-KO mice. A Representative images of H&E
stained lung sections from the indicated genotypes sensitized and challenged with PBS or HDM and clinical scores of peribronchial and
parenchymal inflammation. Scale bar, 100 and 200 μΜ. B Differential cell count analysis with flow cytometry in BALF cells from the indicated
genotypes. C Serum levels of total IgE. D Levels of cytokines in the supernatants of MLN cells after ex vivo stimulation with HDM. E qRT-PCR
analysis of the indicated cytokines in whole lung mRNA. Pooled data from two experiments, n= 8–11 for HDM, n= 4 for PBS. Error bars
indicate SEM. P values reflect the Mann–Whitney U test: *P < 0.05, **P < 0.01, ***P < 0.001.
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compared to WT mice, indicating that RIPK3-dependend necrop-
tosis might take place in these lungs (Fig. 4A).
To circumvent the unsuccessful attempt to detect necroptotic
cells by immunostaining with antibodies against phosphorylated
RIPK3 and MLKL, we sought to examine the presence of dead cells
using terminal deoxynucleotidyl transferase-mediated dUTP nick
end labeling (TUNEL) assay, which stains apoptotic but also
necrotic cells although it cannot distinguish between these types
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of cell death.39 Administration of HDM but not of PBS caused a
transient wave of cell death in WT lungs that started at 5 h (not
shown) and peaked at 24 h after instillation (Fig. 4B). TUNEL+ cells
were mostly evident in the luminal surface of the bronchi and
bronchioles and to a lesser extent in the lung parenchyma. HDM
caused the appearance of increased numbers of TUNEL+ AECs in
the lungs of FADDAEC-KO mice (Fig. 4B, HDM and Fig. 4C),
consistent with the concept that FADD deficiency may sensitize
these cells to necroptosis. However, lung sections from HDM-
treated FADDAEC-KORipk3−/− mice showed similar numbers of
TUNEL+ cells compared to lungs from FADDAEC-KO mice, suggest-
ing that the increased number of TUNEL+ cells in FADDAEC-KO mice
were not due to RIPK3-mediated necroptosis (Fig. 4B, C). To further
investigate this puzzling result, we examined cell death in lungs
from PBS-treated mice and found that PBS instillation caused the
death of AECs in FADDAEC-KO and FADDAEC-KORipk3−/− mice, to an
extent similar to HDM (Fig. 4B, PBS and 4C). In the context of a
more broad analysis including also Scgb1a1-CreTg mice that did
not carry any loxP-flanked Fadd allele we found that intranasal PBS
instillation caused increased AEC death in these animals (Fig. S4A),
indicating that the physical/mechanical stress of the instillation
procedure causes the death of AECs expressing Cre recombinase.
This finding raised the possibility that the exaggerated allergic
inflammation in FADDAEC-KO mice might also be related to the
unspecific increased cell death caused by expression of Cre
recombinase. Therefore, to assess whether the increased AEC
death associated with the expression of the Scgb1a1-Cre
transgene could contribute to the exacerbated HDM-induced
airway inflammation in FADDAEC-KO mice, we examined the
responses of Scgb1a1-CreTg mice to HDM sensitization and
challenge. Scgb1a1-CreTg mice developed signs of asthma
pathology that were indistinguishable from their Scgb1a1-CreWT
littermates, as judged by histopathological analysis (Fig. S4B),
BALF inflammatory cell quantitation (Fig. S4C), TH2 cytokine
secretion by MLN cells (Fig. S4E) and serum IgE production
(Fig. S4D). Moreover, qRT-PCR analysis showed that the mRNAs of
Il-5, Il-13, Il-17 as well as of Ccl2 were induced equally in the lungs
of both Scgb1a1-CreTg mice and control mice (Fig. S4F). Therefore,
the increased occurrence of AEC death due to unspecific Cre
effects did not influence the development of HDM-induced
asthma pathology. The unspecific death of AECs expressing the
Scgb1a1-Cre transgene likely masks the presence of necroptotic
cells in the lungs of FADDAEC-KO mice precluding the accurate
quantification of the extent of necroptosis taking place in these
cells. Taken together, these results showed that the exacerbated
lung inflammation in HDM-challenged FADDAEC-KO mice is
specifically linked to the loss of FADD in AECs and depends on
RIPK3, suggesting that increased necroptosis of FADD-deficient
AECs contributes to the worsening of HDM-induced asthma.
AEC-specific FADD deficiency limits HDM-induced mucus
hypersecretion and AHR
Apart from the impact on allergic airway inflammation, FADD
deficiency caused additional structural changes to the airways.
Histopathologic analysis of PAS-stained lung sections revealed
that the airways of FADDAEC-KO mice contained overall less mucus-
producing goblet cells when compared to their Faddfl/fl littermates
3 days after the last challenge with HDM (Fig. 5A), despite the
increased inflammatory response and the abundance of IL-13.
TUNEL staining did not reveal significant ongoing cell death in the
airways of either genotype at this stage (Fig. 5B). Although
“fragile” AECs are expected to have been washed away during
lavage of the lungs, this result indicates that the reduced numbers
of goblet cells is not the consequence of increased ongoing death
of FADD deficient epithelial cells. The defect in mucus-producing
cells prompted us to investigate the fate of other AEC types in the
lungs of FADDAEC-KO mice. Staining of lung sections with an
antibody against SCGB1A1, a specific marker of Club cells that are
the non-ciliated secretory cells of the airways, showed that their
numbers were significantly reduced in the airways of HDM-treated
FADDAEC-KO mice particularly in severely inflamed bronchi or
bronchioles (Fig. 5C). In contrast, the abundance of ciliated cells,
identified by immunostaining for the transcription factor FOXJ1,
did not differ between FADDAEC-KO and Faddfl/fl littermates
(Fig. 5D). Loss of Club cells activates a repair program in which
basal cells proliferate to replenish the Club cell compartment
through differentiation.40 We therefore assessed the presence of
basal cells in the airways of FADDAEC-KO and control mice by
immunostaining for p63 (Fig. 5E). Indeed, many more airways
containing p63+ basal cells were detected in the lungs of
FADDAEC-KO mice. Interestingly, RIPK3 deficiency limited the
number of airways with p63+ cells, indicating that RIPK3-
dependent mechanisms contribute to the ongoing epithelial cell
injury and/or airway remodeling in FADD deficient AECs.
Consistent with the immunohistochemistry results, the mRNA
levels of Scgb1a1 were significantly downregulated in the lungs of
FADDAEC-KO mice when compared to WT littermates (Fig. 5F).
However, expression levels of Muc5ac, the major mucin that is
induced during allergic airway responses, were mildly reduced.
This effect could be explained by the fact that the mRNA
expression of Spdef, a transcription factor largely responsible for
goblet cell metaplasia, was not altered suggesting that the
transcriptional program for goblet cell differentiation is induced
equally in both FADDAEC-KO and WT mice (Fig. 5F). We
hypothesized that Club cell loss due to RIPK3-dependent
necroptosis during challenge with HDM might cause a shortage
of goblet cell progenitors resulting in less mucus secreting cells.
However, RIPK3 deficiency did not restore the abundance of
mucus producing cells (Fig. 5A) and only partially restored
SCGB1A1 protein expression (Fig. 5C) in FADDAEC-KO mice.
Consistently, RIPK3 deficiency did not normalize the expression
levels of Scgb1a1 and Muc5ac mRNAs in the lungs of FADDAEC-KO
mice (Fig. 5F). These results prompted us to investigate whether
the underlying unspecific cell death caused by the expression of
Cre recombinase might contribute in parallel with RIPK3-
dependent necroptosis to the specific loss of Goblet cells. qRT-
PCR analysis showed that the mRNA expression levels of Muc5ac,
Spdef, Foxj1, Scgb1a1 and p63 were not significantly altered in the
lungs of Scgb1a1-CreTg mice compared to WT littermates (Fig. 5F),
suggesting that the unspecific cell death associated with Cre
expression does not cause the loss of Club cells.
In asthma, the degree of inflammation is thought to correlate
with airflow obstruction and AHR development due to the ensuing
activation of smooth muscle cells. A recent study, using Muc5ac−/−
mice showed that even in the presence of ongoing inflammation
lack of mucus hypersecretion abolishes AHR.41 Given the
phenotype of FADDAEC-KO mice, in which an exacerbated
inflammatory response coincided with less mucus production, we
Fig. 3 RIPK3-dependent AEC necroptosis causes exacerbated HDM-induced airway inflammation in FADDAEC-KO mice. A Representative
images of H&E stained lung sections from the indicated genotypes sensitized and challenged with PBS or HDM and clinical scores of
peribronchial and parenchymal inflammation. Scale bar, 100 and 200 μΜ. B Differential cell count analysis with flow cytometry in BALF cells
from the indicated genotypes. C Serum levels of total IgE. D Levels of cytokines in the supernatants of MLN cells after ex vivo stimulation with
HDM. E qRT-PCR analysis of the indicated cytokines in whole lung mRNA. F FACS plots and absolute numbers of CD11b+ and CD103+ DC
subsets that migrated to MLNs 3 days after HDM instillation. For A–E pooled data from two experiments, n= 10–11 for HDM, n= 3 for PBS. For
F pooled data from two experiments, n= 6 for HDM, n= 3 for PBS. Error bars indicate SEM. P values reflect the Mann–Whitney U test: *P < 0.05,
**P < 0.01, ***P < 0.001.
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were interested to determine the net contribution of these clinical
entities to AHR development. As expected, lung resistance in HDM-
treated Faddfl/fl mice increased considerably upon methacholine
exposure (Fig. 6). Elastance values were also increased and
conversely compliance was reduced. Ripk3−/− mice developed
AHR similar to Faddfl/fl mice. Surprisingly, AEC-specific deletion of
FADD resulted in significant protection from AHR since resistance,
compliance and elastance values were similar to those of PBS-
treated mice. HDM administration in Ripk3−/− mice caused
worsening of lung function in a manner similar to Faddfl/fl mice.
Interestingly, RIPK3 expression mediated at least to some extent
the observed amelioration of AHR in FADDAEC-KO mice, since RIPK3
deficiency partly increased the resistance and elastance para-
meters in FADDAEC-KORipk3−/− mice, suggesting that RIPK3-
dependent mechanisms contribute to the amelioration of lung
function in FADDAEC-KO mice. These results support the concept
that mucus hypersecretion contributes to airway obstruction and
AHR development despite the ongoing inflammation.
DISCUSSION
Regulation of epithelial cell survival and death has emerged as a
key mechanism affecting immune homeostasis in barrier tissues
such as the skin and the intestine. Previous studies showed that
conditional targeting of FADD or Caspase 8 caused epithelial cell
necroptosis resulting in severe inflammation in both the skin and
the intestine.24–26,42,43 In addition, epithelial cell specific RIPK1
deficiency caused skin inflammation by sensitizing keratinocytes
to ZBP1-RIPK3-MLKL-mediated necroptosis,31,34,44,45 and severe
intestinal pathology by sensitizing intestinal epithelial cells to
FADD-caspase-8-mediated apoptosis.31,32 The lung epithelium
also constitutes a barrier against inhaled pollutants, allergens
and pathogens, therefore we wanted to address whether
regulation of epithelial cell death also controls tissue homeostasis
in the lung. Our results presented here show that AEC-specific
ablation of FADD or RIPK1 did not cause spontaneous death of
epithelial cells and did not disturb normal tissue homeostasis in
the lung, in contrast to the findings in the skin and the intestine.
While it remains unclear why the lung epithelium responds
differently from the skin and intestinal epithelium to FADD or
RIPK1 deficiencies, this is likely related to the relatively lower
microbial load in the airways compared to the surface of the skin
and the lumen of the gut.
Whereas FADD ablation in AECs did not disturb normal lung
homeostasis under steady-state conditions, it caused exacerbated
asthma-like lung pathology in response to HDM sensitization and
challenge. AEC-specific FADD deficiency did not affect the
qualitative features of the immune response against HDM, but
rather amplified the underlying type 2 immune response. Our
experiments showed that inhibition of RIPK1 kinase activity, by
crossing to mice expressing kinase-inactive RIPK1, as well as RIPK3
or MLKL deficiency greatly attenuated the severity of airway
inflammation in FADDAEC-KO mice, suggesting that RIPK1-RIPK3-
MLKL-mediated necroptosis of FADD-deficient AECs strongly
contributes to the exacerbation of HDM-induced asthma. Lack of
RIPK1 kinase activity or RIPK3 or MLKL deficiency did not protect
mice with intact FADD signaling from HDM-induced airway
inflammation, showing that RIPK1-RIPK3-MLKL-mediated necrop-
tosis does not play an important role in HDM-induced asthma in
wild type mice. The exact mechanisms by which necroptosis of
FADD-deficient AECs potentiates type 2 inflammation are not yet
fully understood. However, increased numbers of CD103+ DCs,
which are known to present antigens in association with dead
cells,46 were found to migrate in MLNs of FADDAEC-KO but not of
FADDAEC-KO Ripk3−/− mice after HDM instillation, suggesting that
AEC necroptosis contributes to the increased activation and
expansion of this type of DCs. FADD deficiency resulted in a mild
amplification of the underlying TH2 immune response against
HDM, which was dependent on RIPK1-RIPK3 signaling as both the
inhibition of RIPK1 kinase activity and RIPK3 deficiency limited the
Fig. 4 HDM induces death of AECs. A Immunoblot for RIPK3 in whole lung lysates 24 h after HDM exposure. B Representative images from
TUNEL staining in lung sections from mice treated with PBS or HDM for 24 h. Scale bars, 100 μΜ. C Quantification of TUNEL+ cells from (B).
Pooled data from two experiments n= 3–9 for HDM, n= 3–5 for PBS. Error bars indicate SEM. P values reflect the Mann–Whitney U test: *P <
0.05, **P < 0.01, ***P < 0.001.
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excessive production of type 2 cytokines in the lymph nodes and
reduced the expression of type 2 cytokines in lung tissue from
FADDAEC-KO mice. Interestingly, lack of RIPK1 kinase activity, and to
a lesser extent RIPK3 deficiency, limited the activation of TH17
cells, which is associated with more severe asthma endotypes,2 in
FADDAEC-KO mice, suggesting that in the context of type 2
immunity in the lung, AEC necroptosis might potentiate
neutrophil-associated TH17 pathogenic responses. These findings
are consistent with the role of necroptosis in driving inflammatory
responses upon epithelial-specific ablation of FADD or caspase-8
in the intestine and the skin,24,25,43 and identify necroptosis as a
potent amplifier of allergic lung inflammation. HDM could mediate
necroptosis of FADD-deficient AECs directly by activating TLR4
and/or indirectly by inducing the expression of death receptor
ligands such as TNF and TRAIL that are known to be produced
during allergic responses.47
While our genetic studies support a role of necroptosis in
driving the exacerbated HDM-induced lung pathology in FADDAEC-
Fig. 5 AEC-specific FADD deficiency limits HDM-induced mucus hypersecretion and induces epithelial remodeling. A Representative
images of PAS stained lung sections and quantification of mucus content from the indicated genotypes after sensitization and challenge with
HDM. Scale bar, 100 μΜ. B Representative images from lung sections derived from mice after sensitization and challenge with HDM stained
with TUNEL. C–E Representative images and quantification analysis of lung sections derived from mice after sensitization and challenge with
PBS or HDM and immunostained for SCGB1A1 (C), FOXJ1(D) or p63 (E). Scale bars for (C): 100 μΜ, (D, E): 50 μΜ. F qRT-PCR analysis of the
indicated genes in whole lung mRNA isolated from mice with the indicated genotype after sensitization and challenge with HDM. For A, E n=
5–6. For F n= 9–12, from two experiments. Error bars indicate SEM. P values reflect the Mann–Whitney U test: *P < 0.05, **P < 0.01, ***P < 0.001.
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KO mice, we were not able to provide definite evidence of the
presence of necroptotic cells in the lungs of HDM-challenged
animals due to the unavailability of antibodies capable of reliably
and specifically detecting necroptotic cells in situ in tissue
sections. Nevertheless, HDM instillation caused an upregulation
of RIPK3 expression in the lungs of FADDAEC-KO mice, which could
be indicative of ongoing necroptotic cell death of FADD deficient
AECs. Our attempt to detect and quantify dying cells using TUNEL
staining was also hindered by the finding that expression of the
Scgb1a1-Cre transgene in the absence of loxP-flanked alleles
sensitized AECs to death in response to instillation of HDM but
also PBS. Whereas this unspecific cell death associated to Cre
recombinase expression prevented the accurate assessment of
necroptosis caused by FADD deficiency, the finding that Scgb1a1-
CreTg mice did not develop more severe allergic inflammation to
HDM demonstrated that the exacerbated responses in FADDAEC-KO
mice were due to FADD deficiency and not the expression of Cre.
These results also showed that the Scgb1a1-CreTg mice can be
used for the study of allergic inflammation in AEC-specific
conditional knockout mice, however any assessment of cell death
in these mutants needs to be rigorously controlled taking into
account the unspecific cell death associated with the Cre
transgene.
Despite the exacerbated inflammatory response, FADDAEC-KO
mice were protected from AHR development. This protection was
associated with reduced numbers of mucus-producing cells in the
airways of these mice, indicating that airway obstruction due to
mucus hypersecretion contributes substantially to AHR in asthma.
The most plausible scenario for the reduced numbers of Goblet
cells in the airways of FADDAEC-KO mice is the death of their
precursors i.e., the Club cells, as it was also evident by our analysis.
However, RIPK3-dependent necroptosis cannot fully account for
the reduced number of Goblet cells since RIPK3 deficiency did not
restore their numbers. An alternative explanation is that cell death
due to Cre expression contributes in parallel with necroptosis to
the demise of Club cells. Collectively and taking into account the
aforementioned complications, these results support recent
findings suggesting that either genetic41 or pharmacologic48
targeting of mucus or mucus producing cells could be a beneficial
strategy for the control of AHR during asthma.
Necroptosis is considered as a fail-safe cell death mode that
operates in certain conditions such as for example when apoptosis
is inhibited. This is best illustrated in the case of viral infections. In
their attempt to evade host defences and to propagate within
cells, viruses have evolved mechanisms that interfere with cell
death induction. For example, viruses are known to express
caspase inhibitors that are able to block apoptosis execution.49
Some viruses in addition to inhibition of apoptosis express
proteins that interfere with RIPK1/RIPK3 signaling leading to
inhibition of necroptosis, facilitating their replication in the
infected cells.49 Due to its lytic nature, necroptosis is considered
to be an immunogenic form of cell death as opposed to apoptosis
that is thought to elicit no or weak immune responses. Therefore,
whereas necroptosis is considered an important anti-viral defense
mechanism, its beneficial effects in preventing viral replication
and spread are often outweighed by its propensity to trigger
exagerated immune responses that ultimately can cause tissue
damage. For example Influenza virus infection induces
necroptosis-depended hyperinflammation that contributes to
the severity of the disease.50 Intriguingly, the extent to which
FADD deficiency aggravated type 2 inflammation is reminiscent of
the reported amplification of allergic airway inflammation induced
by respiratory viral infections.51,52 Respiratory viruses such as
Rhinovirus (RV) and Respiratory Syncytial Virus (RSV) have severe
effects for patients at risk or with existing asthma.53 However, the
mechanisms by which infections in the respiratory tract lead to
exacerbation of the underlying allergic inflammation are poorly
understood.53 It was shown recently that the RV 3C protease can
modulate cell death by cleaving RIPK1 resulting in suppression of
apoptosis and induction of caspase-independent cell death for
release of viral particles,54,55 indicating that viral infection of AECs
in the lungs can interfere with RIPK1/RIPK3 mediated cell death
pathways. In a more recent study, RSV infection was shown to
induce necroptotic death of human AECs and that both genetic
and pharmacologic inhibition of necroptosis during viral infection
in neonatal mice decreased acute bronchiolitis and protected
mice from the development of asthma-like pathology upon
exposure to cockroach allergen later in life.56 In addition, it has
been reported that transgenic mice overexpressing human
gasdermin B (GSDMB), which induces lytic cell death resembling
pyroptosis, developed asthma-like pathology.57 GSDMB is located
at the 17q21 locus that is consistently associated with asthma and
a splice variant that abolishes the ability to execute pyroptosis in
bronchial epithelial cells was recently associated with lower
asthma risk.58 Collectively, our results in FADDAEC-KO mice
combined with the above observations suggest a possible
causative relationship between viral-induced cell death of AECs
and exacerbation of allergic airway pathology. These findings
Fig. 6 AEC-specific FADD deficiency limits AHR parameters. Resistance, compliance and elastance measurements of lung function in
response to increasing doses of methacholine, as assessed with the flexivent (SCIREQ). n= 7 for PBS (pooled data), n= 6 for HDM from one
experiment. Error bars indicate SEM, p values reflect 2 way ANOVA test: *p < 0.05, **p < 0.001, ***p < 0.001. p values for the 800mg/ml
methacholine dose are depicted.
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warrant further studies to address whether necroptosis inhibition,
e.g., using RIPK1 kinase inhibitors,59 could prevent asthma
exacerbation by viral infections.
MATERIALS & METHODS
Mice
Faddfl/fl,25 Ripk3−/−,60 Ripk1fl/fl,31 Ripk1D138N/D138N36 and Scgb1a1-
cre mice (CBA/C57BL6 F1)29 were described previously. Scgb1a1-
cre mice were backcrossed for 2–3 generations with C57Bl6 mice
before they were used for the generation of conditional knock-out
mice. For the generation of Mlkl−/− mice, Cas9 mRNA together
with the sgRNA targeting the Mlkl gene (5′-CGTCTAG-
GAAACCGTGTGCA-3′) were microinjected into the pronucleus of
fertilized oocytes obtained from Faddfl/fll mice. On the next day,
the injected embryos were transferred to foster mothers and
allowed to develop to term. An Mlkl allele shown to have a 35 bp
deletion at exon 2 resulting in a premature stop codon was
propagated as the Mlkl knockout allele used for this study
(Fig. S3A). Mice were maintained at the SPF animal facilities of the
Institute for Genetics and the CECAD Research Center of the
University of Cologne, under a 12 h light cycle, and given a regular
chow diet (Harlan, diet number 2918 or Prolab Isopro RMH3000
5P76) ad libitum. All animal procedures were conducted in
accordance with European, national and institutional guidelines
and protocols were approved by local government authorities
(Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-
Westfalen, Germany). Mice of the indicated genotype were
assigned at random to groups.
House dust mite-induced asthma model
On day 0, mice were lightly anesthetized with ketamine (80 mg/Kg
Ketamine, 8 mg/Kg xylazine) and received 1 µg HDM (Greer
laboratories) intranasally dissolved in 50 μl of PBS. On days 7–11,
mice were challenged daily with 10 µg HDM intranasally. On day
14, mice were euthanized. For the acute model of HDM mice were
instilled intranasally with either PBS or HDM (100 μg in 50 μl) and
sacrificed 24 h later. All related assays for the analysis of the
immune response have been reported previously15,30,31,61 and are
presented in detail in an online supplement.
Statistical analyses
Data shown in column graphs represent the mean ± s.e.m. For all
experiments, we calculated the difference between groups with
the Mann–Whitney U test for unpaired data (GraphPad Prism).
Differences were considered significant when p value was lower
than 0.05. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.005.
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